Transcendent Capital Group LLC Decreases Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Transcendent Capital Group LLC decreased its position in DocuSign, Inc. (NASDAQ:DOCU) by 13.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,516 shares of the company’s stock after selling 376 shares during the quarter. Transcendent Capital Group LLC’s holdings in DocuSign were worth $226,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Toronto Dominion Bank raised its position in shares of DocuSign by 30.3% during the 3rd quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock valued at $1,624,000 after purchasing an additional 6,081 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of DocuSign by 1.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after buying an additional 16,014 shares in the last quarter. International Assets Investment Management LLC lifted its stake in shares of DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after purchasing an additional 431,295 shares during the last quarter. Quantinno Capital Management LP boosted its stake in DocuSign by 39.5% during the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after buying an additional 57,104 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of DocuSign by 7.1% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after purchasing an additional 85,987 shares during the period. Institutional investors own 77.64% of the company’s stock.

Insider Activity

In other DocuSign news, CFO Blake Jeffrey Grayson sold 15,588 shares of the firm’s stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $97.78, for a total value of $1,524,194.64. Following the transaction, the chief financial officer now owns 85,851 shares in the company, valued at approximately $8,394,510.78. This trade represents a 15.37 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the sale, the director now directly owns 7,736 shares of the company’s stock, valued at $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 693,773 shares of company stock worth $66,727,926 over the last quarter. 1.66% of the stock is currently owned by corporate insiders.

DocuSign Trading Down 0.3 %

DOCU stock opened at $83.69 on Tuesday. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The business’s 50-day moving average is $91.45 and its 200 day moving average is $77.09. The stock has a market cap of $16.91 billion, a price-to-earnings ratio of 17.26, a PEG ratio of 6.94 and a beta of 0.89.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on DOCU. Robert W. Baird raised their target price on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Tuesday, February 4th. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Piper Sandler raised their price target on shares of DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Finally, UBS Group lifted their target price on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, DocuSign presently has an average rating of “Hold” and a consensus target price of $92.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.